Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death sudden/cardiorespiratory arrest; Death sudden/cardiorespiratory arrest; Asystole; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number ES-AEMPS-799295. An 87-year-old male patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 18Mar2021 (Batch/Lot Number: ET3620) as SINGLE DOSE for covid-19 immunisation. The patient received first dose of COMIRNATY on 25Feb2021 (lot number: EP2163) for COVID-19 vaccination. Medical history included glaucoma, COPD, Arterial hypertension. The patient''s concomitant medications were not reported. On 19Mar2021, the patient experienced death sudden due cardiorespiratory arrest. The report described that: "We were notified for possible cardiorespiratory arrest. Despite the fact that the son (nurse) began basic CPR maneuvers for 10-15 min until our arrival, the absence of vital signs persisted and the ECG revealed asystole." The patient underwent lab tests and procedures which included ECG: asystole on 19Mar2021. The patient died on 19Mar2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cardiorespiratory arrest; Sudden death; Asystole
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166